Equity Capital Markets

Company · CIK 2131524

Braveheart Bio, Inc.

CIK2131524 (SEC EDGAR)
Industry (SIC)2834 — Pharmaceutical Preparations
Incorporated inDE
Business addressCA
ListedBRVE (Nasdaq)
First annual or quarterly report2026-09-08

Offerings

1 registration
RegistrationLabel and statusFirst filedLast eventFilings
333-297456
IPOFinal prospectus
 2026-07-152026-08-064

Filings

5
FiledFilingRegistrationAccession
2026-08-06424B4Final prospectus 333-2974560001628280-26-054354
2026-08-05EFFECTDeclared effective 333-2974569999999995-26-002550
2026-07-30S-1/AAmendment 333-2974560001628280-26-050756
2026-07-15S-1Registration filed 333-2974560001628280-26-048213
2026-04-29DRSDraft made public 377-093090001628279-26-000549

All filings of this company · CSV